Cambridge Nutritional Sciences plc (AIM: CNSL)

Market Cap	7.85M
Revenue (ttm)	8.97M
Net Income (ttm)	174.00K
Shares Out	237.95M
EPS (ttm)	0.00
PE Ratio	41.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,723
Open	3.588
Previous Close	3.550
Day's Range	3.511 - 3.588
52-Week Range	2.300 - 4.483
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 22, 2024

About CNSL

Cambridge Nutritional Sciences plc, together with its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, North America, South/Central America, India, rest of Asia and the Far East, Africa, and the Middle East. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the FoodPrint brand. It also provides clinical analysis to the general public, clinics, and health profe...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1987
• Employees: 94
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: CNSL

Financial Performance

In 2023, CNSL's revenue was 9.77 million, an increase of 29.53% compared to the previous year's 7.55 million. Losses were -328,000, -91.50% less than in 2022.